نتایج جستجو برای: bupropion reserpine

تعداد نتایج: 3330  

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 1989
A J Bean M J During A Y Deutch R H Roth

Interactions between striatal dopamine (DA) and neurotensin (NT) have been suggested by anatomical, behavioral, and biochemical studies. Nigrostriatal DA neurons, in contrast to mesocorticolimbic DA neurons, do not appear to contain NT. Thus, distinct neuronal elements subserve interactions between DA and NT within the striatum. We have previously demonstrated that reserpine-induced depletion o...

Journal: :The Kurume medical journal 1966
K Takasak

It has been reported that reserpine causes a prolonged hypertension after the pretreatment of ephedrine and metamphetamine46'47. This hypertension was observed in the previous experiments and the mechanism of the drugs producing the hypertension was discussed. Pheniprazine was proposed as a monoamine oxidase inhibitor by Horita , and reserpine produced a prolonged hypertension after the adminis...

Journal: :Indian journal of experimental biology 2009
Priyanka Mehta Kunwar Bahadur Singh

Reserpine functions as an anti-stress agent providing relaxation to animals under stressful conditions. An attempt was made to find out functions of reserpine in unstressed albino rats and its role in steroidogenesis. The effects of the drug (25 and 35 microg, im daily for 3-5 days) were observed by recording the changes in body weights, concentration of ascorbate (liver and adrenals) and chole...

2010
Aksana Vasilyeva Jill E. Clodfelter Michael J. Gorczynski Anthony R. Gerardi S. Bruce King Freddie Salsbury Karin D. Scarpinato

Mismatch repair proteins modulate the cytotoxicity of several chemotherapeutic agents. We have recently proposed a "death conformation" of the MutS homologous proteins that is distinguishable from their "repair conformation." This conformation can be induced by a small molecule, reserpine, leading to DNA-independent cell death. We investigated the parameters for a small reserpine-like molecule ...

Journal: :Pulmonary pharmacology & therapeutics 2006
Fábio M Haggsträm José M Chatkin Eliana Sussenbach-Vaz Débora H Cesari Claudia F Fam Carlos C Fritscher

PURPOSE AND METHODS Cognitive behavior therapy (CBT) constitutes the basis of smoking cessation programs. Quitting rates are usually increased by the concomitant use of CBT and pharmacotherapy. There are studies showing the efficacy of bupropion and nortriptyline compared to placebo, but there is just one published comparison between these drugs, unfortunately with low power to detect significa...

2015
Joshua D. Stein Nidhi Talwar Jae H. Kang Olivia I. Okereke Janey L. Wiggs Louis R. Pasquale

OBJECTIVE Tumor Necrosis Factor (TNF) mediates retinal ganglion cell death in glaucoma. Anti-TNF drugs are neuroprotective in an animal model of glaucoma. It is unclear whether medications with anti-TNF properties such as bupropion have an impact on the risk of developing open-angle glaucoma (OAG) in humans. The purpose of this study is to determine whether bupropion use alters the risk of deve...

Journal: :Journal of clinical psychopharmacology 2005
A Eden Evins Corinne Cather Thilo Deckersbach Oliver Freudenreich Melissa A Culhane Casey M Olm-Shipman David C Henderson David A Schoenfeld Donald C Goff Nancy A Rigotti

The objective of this study was to examine the efficacy of bupropion for smoking cessation in patients with schizophrenia. Adults with schizophrenia who smoked more than 10 cigarettes per day and wished to try to quit smoking were recruited from community mental health centers, enrolled in a 12-week group cognitive behavioral therapy intervention, and randomly assigned to receive either bupropi...

Journal: :Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2001
A E Evins V K Mays N A Rigotti T Tisdale C Cather D C Goff

The purpose of this study was to investigate the effect of adding sustained-release (SR) bupropion to cognitive behavioral therapy (CBT) on smoking behavior and stability of psychiatric symptoms in patients with schizophrenia. We conducted a 3-month, double-blind, placebo-controlled trial of bupropion SR, 150 mg/day, added to a concurrent CBT program with 3-month follow-up in 19 stable outpatie...

2013
Karine Giasson-Gariépy Didier Jutras-Aswad

Antidepressants can increase the spontaneous risk of hypomania or mania when used for treatment in affective disorders. When prescribed as an antidepressant, bupropion is generally considered to have a lower relative risk of inducing mood shifts. We describe the case of a 67-year-old man known for dysthymic disorder in remission on quetiapine and venlafaxine who experienced a first lifetime epi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید